Evidence map›Paper›PMID 30536181›Full record

ArticlePediatric nephrology (Berlin, Germany)2019

Correction to: An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28 days to < 6 years with chronic kidney disease receiving dialysis.

Winnie Y Sohn, Anthony A Portale, Isidro B Salusky, Hao Zhang, Lucy L Yan, Bella Ertik, Shahnaz Shahinfar, Edward Lee, Bastian Dehmel, Bradley A Warady

Open access · bronzeAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Pediatric nephrology (Berlin, Germany), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 12 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Winnie Y SohnAmgen, Inc., One Amgen Center Dr. M/S 38-4-A, Thousand Oaks, CA, 91320, USA. wkim@amgen.com.
Anthony A PortaleUCSF Benioff Children's Hospital, San Francisco, CA, USA.
Isidro B SaluskyDavid Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Hao ZhangAmgen, Inc., One Amgen Center Dr. M/S 38-4-A, Thousand Oaks, CA, 91320, USA.
Lucy L YanAmgen, Inc., One Amgen Center Dr. M/S 38-4-A, Thousand Oaks, CA, 91320, USA.
Bella ErtikAmgen, Inc., One Amgen Center Dr. M/S 38-4-A, Thousand Oaks, CA, 91320, USA.
Shahnaz ShahinfarS. Shahinfar Consulting and Childrens Hospital of Philadelphia, Philadelphia, PA, USA.
Edward LeeAmgen, Inc., One Amgen Center Dr. M/S 38-4-A, Thousand Oaks, CA, 91320, USA.
Bastian DehmelAmgen, Inc., One Amgen Center Dr. M/S 38-4-A, Thousand Oaks, CA, 91320, USA.
Bradley A WaradyChildren's Mercy Hospital, Kansas City, MO, USA.
Amgen (United States) · USChildren's Hospital of Philadelphia · USChildren's Mercy Hospital · USUCSF Benioff Children's Hospital · USUniversity of California, Los Angeles · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The original version of this article unfortunately contained three mistakes. In Table 1, the last line under "Key Inclusion Criteria" should read "Normal or clinically acceptable ECGs at screening and at day - 1." In addition, the abbreviation "IP" in the legend to Table 1 stands for "investigational product."

Identifiers

PMID30536181
PMCPMC6828146
OpenAlexW2888045599

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.